Comparing two minimally invasive surgeries for rectal growths
Part of Cancer, Digestive system clinical trials.
This trial compares two procedures to remove large, non-cancerous growths from the lower rectum. It aims to see which method is safer and more effective for patients with these specific types of growths.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You have a growth (lesion) on your rectum that is flat and larger than 2 cm.
- The growth is located in the lower part of your rectum (within 15 cm of the anal opening).
- You have not had any previous treatment for this growth, such as an endoscopic removal or radiation therapy.
- You do not have inflammatory bowel disease (like Crohn's or ulcerative colitis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of minimally invasive surgery (robotic-assisted and laparoscopic) for middle and low rectal cancer. The goal is to see which approach offers better outcomes for patients who qualify.
This trial tests a newer, possibly faster method (ESISD) for removing a certain type of large, flat growth in the rectum, compared to the standard method (CESD). It may be an option if you have a growth that is not too deep and is easy to reach.
This study compares two minimally invasive endoscopic techniques—ESD and EPMR—for removing small neuroendocrine tumors (slow-growing hormone-producing tumors) in the rectum. The goal is to see which approach works better and is safer for patients.
This trial tests a new robotic system to remove large, flat growths in the rectum without traditional surgery. It may help people who have early-stage rectal tumors that are too big for standard removal methods.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial compares two minimally invasive methods to remove small rectal neuroendocrine tumors (less than 1 cm) during a colonoscopy. It may help patients avoid major surgery while still effectively treating the tumor.
Hear when a new Rectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.